7744 — Deck

Noritsu Koki · 7744 · TSE

Noritsu Koki is a Japanese holding company built on three niche-leader subsidiaries — AlphaTheta (the global standard in DJ equipment), JLab (the leading sub-$100 audio brand at U.S. mass retail), and Teibow (the world leader in marking-pen nibs).

$12.81
Price
$460M
Market cap
$680M
Revenue (FY24)
$375M
Net cash
Listed 1962; minilabs collapsed in the 2000s and the photo business was sold for parts in 2016; split-adjusted shares 10×'d from $1.80 in mid-2016 to $12.81 today, sitting 13% below the February 2026 $14.80 high.
2 · The tension

Three hundred and seventy-five million dollars of net cash sits on a $460M market cap. What management does with it decides everything.

  • Cheap is the easy part. EV/EBITDA 0.6×, P/E 4.5×, P/B 0.33×. Net cash of $375M equals 81% of the share price — the operating engine is priced at roughly half a year's EBITDA.
  • The bull bet — payout follows through. FY25 guides 84% total payout via DOE 3.5% plus buyback. A $9M March 2026 Treasury purchase already printed; share count fell from 36.19M to 35.53M.
  • The bear bet — fourth-business M&A. The mid-term plan earmarks $375M–$625M for an unannounced fourth pillar by FY30. The same 47.8% Nishimoto family that fired the entire board in 2008 still controls the cap table.
The April 2026 SENQCIA close ($519M from a fund-end Lone Star vehicle) is the first hard datapoint — the Q1 print on May 15 reveals the goodwill ratio.
3 · The engine

Three subsidiaries, one matters. AlphaTheta is 73% of group EBITDA and the global DJ-rider standard.

$112M
AlphaTheta EBITDA 72.6% of group
28.2%
Segment EBITDA margin fabless model
~70%
Global DJ share club rider standard
11.2%
R&D / sales vs JLab 0.4%

AlphaTheta is fabless — production outsourced — so the next dollar of DJ-equipment revenue drops through at near-100% gross margin once hardware is designed. That mechanic produced the FY24 group EBITDA margin of 22.8% on revenue growth alone. The risk to underwrite over the next 18 months is whether an own-factory commitment converts a 28%-margin asset-light business into one funding capex against a much lower incremental return.

4 · Variant perception

The marginal buyer is screening the wrong company.

  • Stale databases. Morningstar's company description still lists healthcare, drug discovery, senior life and agribusiness as primary segments — businesses exited or monetised between 2016 and 2024. Google Finance lists the wrong CEO.
  • Two analysts. That is it. A $460M holdco with three globally-dominant niches has near-zero institutional research footprint. The mean target of $19.50 implies 52% upside; the multiple has not moved off 0.4× P/B in nine years.
  • The unlock is mechanical. The July 2025 3:1 split brought the per-share entry from $38.50 to $12.81 — Japanese retail screens see the name for the first time, and ROE crossing 8% on the FY25 print triggers TSE-Prime quant-screen inclusion.
Consensus is not 'Noritsu is a value trap.' Consensus is 'we don't know what Noritsu is.'
5 · Money picture

FY24 produced the best margins of the decade against the strongest balance sheet ever held.

$680M
Revenue (FY24) +18.3% YoY
22.8%
EBITDA margin vs 5–10% pre-COVID
$375M
Net cash +$740M swing since FY21
7.5%
ROE FY30 plan target 10%

A $770M JMDC disposal gain in FY22 funded the cash-positive flip; subsequent operating leverage from AlphaTheta's fabless model and a $45M yen tailwind on revenue pushed the operating margin from 1.7% in FY22 to 19.3% in FY24. The hole in the story is ROE — at 7.5% it sits below the 8% TSE-Prime quant threshold, and the equity base keeps growing faster than earnings until the buyback pace accelerates.

6 · Catalyst calendar

Sixteen days to a print that resolves three threads at once.

  • May 15 — Q1 FY26 results. First quarter consolidating SENQCIA, the $519M Lone Star carve-out closed April 28. The PPA disclosure shows the goodwill ratio — the bear's 'cash deployed at any price' priors stand or fall on this number.
  • JLab tariff response. Management modelled an $18M EBITDA hit from US reciprocal tariffs offset by $15M of price hikes; $20-earbud price elasticity is the unverified assumption. Q1 segment gross margin reveals whether the offset works.
  • Capital return cadence. $9M of the $19M buyback authorisation is residual after the March execution. A follow-on tranche before the AGM resolutions stale forces the bear to reweight the controller-extraction priors.
Calendar density is low; signal density is high. May 15 and August 13 carry the entire decision-relevant six-month window.
7 · Bull and Bear

Lean long, wait for confirmation — the cheap math is the easy part; the cash deployment is the contract.

  • For. Net cash worth 81% of the share price at 0.6× EV/EBITDA. AlphaTheta's 28.2% fabless margin holds well above the 19.7% FY23 run-rate even after stripping the $45M yen tailwind.
  • For. $9M March 2026 buyback printed; share count down 1.8%. Iwakiri walked from Serato after 15 months of strategic capital rather than overpay, and JMDC was monetised at peak — the empirical inverse of the 'deploy at any price' bear case.
  • Against. 47.8% Nishimoto family stake is the same family that fired the entire board in 2008; the mid-term plan earmarks $375M–$625M for an unannounced fourth business by FY30.
  • Against. Goodwill plus intangibles equal $810M — 88% of consolidated equity, amortising at 30–50 year effective lives. A second JLab impairment under tariff stress lands directly on book.
My view — the 84% guided payout and the disciplined capital track record (Serato cancelled, JMDC monetised at peak) tip the lean. A 'fourth business' announcement of any real size before May 15 flips it back.

Watchlist to re-rate: (1) AlphaTheta segment EBITDA margin net of the -$5M FX disclosure on May 15; (2) SENQCIA goodwill ratio in the Q1 PPA; (3) Buyback follow-on authorisation before the AGM resolutions stale.